UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Hamilton Point Investment Advisors LLC

Hamilton Point Investment Advisors LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 324.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,747 shares of the healthcare conglomerate's stock after acquiring an additional 1,335 shares during the quarter. Hamilton Point Investment Advisors LLC's holdings in UnitedHealth Group were worth $884,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. M&T Bank Corp lifted its stake in shares of UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock worth $128,975,000 after purchasing an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. lifted its stake in shares of UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock worth $26,060,000 after acquiring an additional 41,308 shares in the last quarter. Parsifal Capital Management LP acquired a new position in shares of UnitedHealth Group in the third quarter worth about $21,165,000. Finally, Signal Advisors Wealth LLC lifted its stake in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock worth $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $545.29 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a fifty day moving average of $537.14 and a 200-day moving average of $564.96. The company has a market capitalization of $501.82 billion, a PE ratio of 35.18, a price-to-earnings-growth ratio of 1.46 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.83 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.64 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Finally, Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.